Patents Assigned to SUDO BIOSCIENCES LIMITED
  • Patent number: 12668594
    Abstract: Described herein are compounds that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: June 30, 2026
    Assignee: SUDO BIOSCIENCES LIMITED
    Inventors: Anjali Pandey, Gregory Dietsch, Bhaskar Chaudhuri, Swapan Kumar Samanta, Seetharaman Manojveer, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh Kalva
  • Patent number: 12600721
    Abstract: Described herein are compounds that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: April 14, 2026
    Assignee: SUDO BIOSCIENCES LIMITED
    Inventors: Anjali Pandey, Gregory Dietsch, Bhaskar Chaudhuri, Seetharaman Manojveer, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh Kalva
  • Patent number: 12122785
    Abstract: Described herein are compounds of Formula (I) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
    Type: Grant
    Filed: January 27, 2023
    Date of Patent: October 22, 2024
    Assignee: SUDO BIOSCIENCES LIMITED
    Inventors: Anjali Pandey, Gregory Dietsch, Bhaskar Chaudhuri, Seetharaman Manojveer, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh Kalva
  • Patent number: 12103937
    Abstract: Described herein are compounds of Formula (XIV) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: October 1, 2024
    Assignee: SUDO BIOSCIENCES LIMITED
    Inventors: Anjali Pandey, Gregory Dietsch, Seetharaman Manojveer, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh Kalva
  • Patent number: 12084458
    Abstract: Described herein are compounds of Formula (XIII) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: September 10, 2024
    Assignee: SUDO BIOSCIENCES LIMITED
    Inventors: Anjali Pandey, Gregory Dietsch, Seetharaman Manojveer, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh Kalva
  • Patent number: 11613548
    Abstract: Described herein are compounds of Formula (XVII) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of Using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: March 28, 2023
    Assignee: SUDO BIOSCIENCES LIMITED
    Inventors: Anjali Pandey, Gregory Dietsch, Bhaskar Chaudhuri, Seetharaman Manojveer, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh Kalva